Swiss National Bank’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
110,200
-12,900
| -10% | -$145K | ﹤0.01% | 2041 |
|
|
2025
Q1 | $563K | Sell |
123,100
-10,000
| -8% | -$45.7K | ﹤0.01% | 2321 |
|
|
2024
Q4 | $751K | Buy |
133,100
+18,000
| +16% | +$102K | ﹤0.01% | 2319 |
|
|
2024
Q3 | $557K | Hold |
115,100
| – | – | ﹤0.01% | 2414 |
|
|
2024
Q2 | $562K | Buy |
115,100
+11,900
| +12% | +$58.1K | ﹤0.01% | 2393 |
|
|
2024
Q1 | $1.37M | Sell |
103,200
-5,300
| -5% | -$70.4K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $1.51M | Buy |
108,500
+13,200
| +14% | +$184K | ﹤0.01% | 2003 |
|
|
2023
Q3 | $1.26M | Buy |
95,300
+7,700
| +9% | +$102K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $1.64M | Buy |
87,600
+14,500
| +20% | +$272K | ﹤0.01% | 2020 |
|
|
2023
Q1 | $1.05M | Sell |
73,100
-6,500
| -8% | -$93.7K | ﹤0.01% | 2222 |
|
|
2022
Q4 | $1.54M | Buy |
79,600
+3,300
| +4% | +$63.9K | ﹤0.01% | 2063 |
|
|
2022
Q3 | $2.62M | Buy |
76,300
+30,900
| +68% | +$1.06M | ﹤0.01% | 1693 |
|
|
2022
Q2 | $694K | Buy |
45,400
+5,500
| +14% | +$84.1K | ﹤0.01% | 2524 |
|
|
2022
Q1 | $911K | Buy |
39,900
+3,000
| +8% | +$68.5K | ﹤0.01% | 2452 |
|
|
2021
Q4 | $1.36M | Buy |
+36,900
| New | +$1.36M | ﹤0.01% | 2292 |
|